相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。70MO Genomic profiling to expand precision cancer medicine in the real world: The ROME trial
A. Botticelli et al.
ESMO Open (2023)
Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards
Tara M. Love et al.
PLOS ONE (2022)
Patient attrition in Molecular Tumour Boards: a systematic review
Hannah Frost et al.
BRITISH JOURNAL OF CANCER (2022)
Clinical cancer genomic profiling
Debyani Chakravarty et al.
NATURE REVIEWS GENETICS (2021)
Evolution of the Randomized Clinical Trial in the Era of Precision Oncology
Joseph C. Del Paggio et al.
JAMA ONCOLOGY (2021)
Molecular Tests and Target Therapies in Oncology: recommendations from the Italian workshop
Carmine Pinto et al.
FUTURE ONCOLOGY (2021)
Price Models for Multi-indication Drugs: A Systematic Review
Carlos Campillo-Artero et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2020)
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
Shumei Kato et al.
NATURE COMMUNICATIONS (2020)
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With BRAF V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study
Vivek Subbiah et al.
JCO PRECISION ONCOLOGY (2019)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication
Steven Lemery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY
Simona Montilla et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2015)
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Indication-Specific Pricing for Cancer Drugs
Peter B. Bach
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)